Nimodipine IV is administered by continuous infusion. The typical starting dose is 1 mg/hour. This rate can be increased gradually based on the patient’s response and tolerance, but should not exceed a maximum of 6 mg/hour.
Monitoring Blood Pressure
Closely monitor blood pressure during and after infusion. Hypotension is a potential side effect and requires dose adjustment or discontinuation. Regular blood pressure checks are crucial.
Adjusting the Infusion Rate
Adjust the infusion rate according to individual patient needs and clinical response. Titration should be cautious and incremental. Always follow physician instructions.
Preparation and Administration
Nimodipine for IV use comes as a concentrate that requires dilution. Always refer to the specific instructions provided by the manufacturer for correct preparation and dilution procedures before administration. Aseptic techniques are mandatory.
Important Considerations
| Renal Impairment | Dose adjustment may be necessary; consult product labeling for guidance. |
| Hepatic Impairment | Careful monitoring is needed; dose reduction might be required. |
| Elderly Patients | Start with a lower dose and monitor closely for adverse effects. |
Potential Side Effects
Common side effects include hypotension, headache, flushing, and nausea. Less frequent but potentially serious side effects include bradycardia and arrhythmias. Promptly report any unusual symptoms to the healthcare provider.
Storage
Store Nimotop IV solution according to manufacturer’s instructions. Generally, this involves refrigeration. Always check the expiry date before use.
